JPWO2023099668A5 - - Google Patents
Info
- Publication number
- JPWO2023099668A5 JPWO2023099668A5 JP2024532973A JP2024532973A JPWO2023099668A5 JP WO2023099668 A5 JPWO2023099668 A5 JP WO2023099668A5 JP 2024532973 A JP2024532973 A JP 2024532973A JP 2024532973 A JP2024532973 A JP 2024532973A JP WO2023099668 A5 JPWO2023099668 A5 JP WO2023099668A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- seq
- amino acid
- acid sequence
- binding protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163285513P | 2021-12-03 | 2021-12-03 | |
| US63/285,513 | 2021-12-03 | ||
| PCT/EP2021/086689 WO2022136209A1 (en) | 2020-12-22 | 2021-12-20 | Interleukin 5 binding protein dosage regimen |
| EPPCT/EP2021/086689 | 2021-12-20 | ||
| US202263349622P | 2022-06-07 | 2022-06-07 | |
| US63/349,622 | 2022-06-07 | ||
| PCT/EP2022/084075 WO2023099668A1 (en) | 2021-12-03 | 2022-12-01 | Interleukin 5 binding protein dosage regimen for use in treating polyangiitis, hypereosinophilic syndrome, hypereosinophilic syndrome chronic rhinosinusitis with nasal polyps (crswnp), or chronic rhinosinusitis without nasal polyps (crssnp) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024542777A JP2024542777A (ja) | 2024-11-15 |
| JPWO2023099668A5 true JPWO2023099668A5 (enExample) | 2025-12-08 |
Family
ID=84688427
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024532973A Pending JP2024542777A (ja) | 2021-12-03 | 2022-12-01 | 多発血管炎、好酸球増多症候群、好酸球増多症候群、鼻ポリープを伴う慢性副鼻腔炎（ｃｒｓｗｎｐ）又は鼻ポリープを伴わない慢性副鼻腔炎（ｃｒｓｓｎｐ）の処置における使用のためのインターロイキン５結合タンパク質投与レジメン |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250042985A1 (enExample) |
| EP (1) | EP4440617A1 (enExample) |
| JP (1) | JP2024542777A (enExample) |
| CA (1) | CA3239667A1 (enExample) |
| WO (1) | WO2023099668A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026047072A1 (en) * | 2024-08-30 | 2026-03-05 | Glaxosmithkline Intellectual Property Development Limited | Medical use |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI799417B (zh) | 2017-05-26 | 2023-04-21 | 英商葛蘭素史克智慧財產發展有限公司 | 生物製藥組成物及相關方法 |
-
2022
- 2022-12-01 CA CA3239667A patent/CA3239667A1/en active Pending
- 2022-12-01 EP EP22830693.2A patent/EP4440617A1/en active Pending
- 2022-12-01 WO PCT/EP2022/084075 patent/WO2023099668A1/en not_active Ceased
- 2022-12-01 US US18/715,320 patent/US20250042985A1/en active Pending
- 2022-12-01 JP JP2024532973A patent/JP2024542777A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025169389A5 (enExample) | ||
| JP2023052458A5 (enExample) | ||
| RU2006120950A (ru) | Антитело к cd40: препарат и способы | |
| KR20060123483A (ko) | 허혈성 병변의 치료 및 예방을 위한 트레프로스티닐의 용도 | |
| CN114558129A (zh) | 用于降低心血管风险的方法 | |
| IL316408A (en) | A safe and effective method for treating psoriasis with a specific anti-IL23 antibody | |
| JP2019521156A5 (enExample) | ||
| US20230331834A1 (en) | Method of treating tendinopathy using interleukin-17 (il-17) | |
| JP2019521156A (ja) | Ｉｌ−１７アンタゴニストを用いて初発プラーク型乾癬を治療する方法 | |
| EP2138513B1 (en) | Pharmaceutical compositions of antibodies for diseases caused by viruses | |
| Co et al. | Serial office-based intralesional injection of cidofovir in adult-onset recurrent respiratory papillomatosis | |
| JPWO2020136101A5 (enExample) | ||
| JPWO2023099668A5 (enExample) | ||
| KR100302994B1 (ko) | 약독화된비면역원성폭스바이러스또는파라폭스바이러스로부터멀티포텐트파라폭스면역유발인자의약제로서이용하는새로운적용 | |
| JP2022543956A (ja) | 安定なアルブビルチド組成物 | |
| CA3176673A1 (en) | Pan-elr+ cxc chemokine antibodies for the treatment of respiratory disease | |
| JPWO2020012244A5 (enExample) | ||
| JPWO2022136209A5 (enExample) | ||
| JPWO2019186369A5 (enExample) | ||
| JPWO2020245766A5 (enExample) | ||
| JPWO2023095000A5 (enExample) | ||
| RU2023101205A (ru) | Препарат для лечения опухоли | |
| RU2180532C2 (ru) | Способ лечения папилломатоза | |
| IL316022A (en) | Method of treating mild to moderate psoriasis with il-23 specific antibody | |
| JPWO2020128864A5 (enExample) |